论文部分内容阅读
近年来,我们用前列腺素E_1(PGE_1)治疗高粘滞血症,观察其治疗前后的血液流变学变化,结果如下。1.病例选择:治疗组42例中,男30例,女12例;年龄39～76岁。临床前期高粘滞血症5例,临床期高粘滞血症37例,其中冠心病16例(合并心衰2例)、动脉硬化性脑梗塞15例、脑动脉硬化2例、高血压病2例、血栓性脉管炎2例。对照组32例,其性别、年龄、原发病、血液流变学结果与治疗组具有可比性。
In recent years, we used prostaglandin E_1 (PGE_1) treatment of hyperviscosity, observed changes in hemorheology before and after treatment, the results are as follows. 1. Case Selection: 42 cases of treatment group, 30 males and 12 females; aged 39 to 76 years. 5 cases of hyperviscosity in preclinical period, 37 cases of hyperviscosity in clinic, 16 cases of coronary heart disease (2 cases with heart failure), 15 cases of arteriosclerotic cerebral infarction, 2 cases of cerebral arteriosclerosis, 2 cases, 2 cases of thrombotic vasculitis. The control group of 32 cases, its gender, age, primary disease, hemorheology results comparable with the treatment group.